Trademark: 79324831
Word
SEVER PHARMA SOLUTIONS
Status Date
Tuesday, June 11, 2024
Filing Date
Thursday, August 19, 2021
Published for Opposition
Tuesday, October 25, 2022
Abandoned Date
Tuesday, June 11, 2024
5 Pharmaceuticals, medical and veterinary preparations, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; plasters for medical purposes, materials for dressings being medical dressings; medical plasters; material for stopping teeth, dental wax
35 Wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies
44 Medical consultations; medical counseling; medical information; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; nursing, medical; Pharmaceutical compounding services; provision of pharmaceutical medical information; Pharmaceutical advice
10 Surgical apparatus and instruments; Surgical apparatus and instruments for medical, dental or veterinary use
42 Providing medical and scientific research information about the results of clinical trials for pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; scientific research in the nature of conducting clinical trials for pharmaceutical products for others; development of pharmaceutical preparations and medicines; pharmaceutical products development; research on the subject of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical research services; medical research
Nov 8, 2021
New Application Office Supplied Data Entered
Nov 4, 2021
Sn Assigned For Sect 66a Appl From Ib
Nov 12, 2021
Application Filing Receipt Mailed
May 23, 2022
Assigned To Examiner
May 30, 2022
Non-Final Action Written
May 31, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jun 23, 2022
Refusal Processed By Mpu
Jun 23, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 13, 2022
Refusal Processed By Ib
Sep 8, 2022
Teas Response To Office Action Received
Sep 8, 2022
Correspondence Received In Law Office
Sep 8, 2022
Teas/Email Correspondence Entered
Sep 19, 2022
Approved For Pub - Principal Register
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Oct 25, 2022
Published For Opposition
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2022
Extension Of Time To Oppose Received
Dec 1, 2022
Teas Withdrawal Of Attorney Received
Dec 1, 2022
Withdrawal Of Attorney Granted
Dec 2, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 2, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 2, 2022
Teas Change Of Correspondence Received
Feb 1, 2023
Teas Post Publication Amendment Received
Feb 13, 2023
Assigned To Petition Staff
Feb 13, 2023
Changes/Corrections After Pub Approval Entered
Feb 21, 2023
Opposition Notice (Ib Refusal) Created
Feb 21, 2023
Opposition Notice (Ib Refusal) Sent To Ib
Feb 22, 2023
Opposition Instituted No. 999999
Mar 21, 2023
Refusal Processed By Ib
Apr 5, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 5, 2023
Notification Of Possible Opposition Sent To Ib
Oct 21, 2023
Change Of Name/Address Rec'd From Ib
Apr 24, 2023
Notification Of Possible Opposition - Processed By Ib
Jun 6, 2024
Opposition Sustained No. 999999
Jun 6, 2024
Abandonment - After Inter Partes Decision
Jun 6, 2024
Opposition Terminated No. 999999
Jun 30, 2024
Death Of International Registration
Jun 30, 2024
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Jun 6, 2024
Abandonment Notice E-Mailed - Inter Partes Decision
Trademark Alertz updated from USPTO on 2030-01-24
